ICEF-15

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameICEF-15

Drug Alias Nameautologous Skeletal Muscle Derived Cells - Innovacell Biotechnologie GmbHaSMDC - Innovacell Biotechnologie GmbHNPJ 5007ICEF-15

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapyCell and gene therapy > Cell therapy > Source of cells > Skeletal muscle-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsFecal Incontinence

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNorgine

China Registration ClassN/A

Develop Information

Active CompaniesNorgine

Inactive CompaniesN/A

Active IndicationsFecal Incontinence

Inactive IndicationsN/A

Other Information

ATC CodeN/A